PMD31 Cost-Effectiveness Analysis of EGFR Testing and Gefitinib for Non-Small-Cell Lung Cancer (NSCLC) in Japan

Jun 1, 2012, 00:00 AM
10.1016/j.jval.2012.03.371
https://www.valueinhealthjournal.com/article/S1098-3015(12)00436-6/fulltext
Section Title : Medical Device/Diagnostics
Section Order : 1154
First Page : A67
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00436-6&doi=10.1016/j.jval.2012.03.371
HEOR Topics :
Tags :
Regions :